☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Non-Dialysis-Dependent
Astellas Reports Submission of sNDA to MHLW for Evrenzo (roxadustat) to Treat Anemia Associated with Chronic Kidney Disease in Non...
January 30, 2020
AstraZeneca and FibroGen's Roxadustat Receive NMPA's Approval for the Treatment of Anemia in Non-Dialysis-Dependent Patients with...
August 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.